A new colorectal cancer screening test will be available in the spring. More practical and efficient, it will replace the test offered as part of the national screening program.
Detect twice as many cases of colorectal cancer: this is what new immunological tests will allow. As of the spring, it will replace the test offered so far as part of the national organized screening program for colorectal cancer.
More practical, efficient and reliable
Supported 100% without advance costs, this simple, quick and painless test is to be performed at home. More practical to use, it only requires a single stool sample compared to six previously.
The new test is also more efficient, since it has a higher sensitivity and allows better detection of cancers and precancerous lesions. Literature data show that this technology can detect 2 to 2.5 times more cancers and 3 to 4 times more adenomas.
Finally, this immunological test is also more reliable, thanks to the use of antibodies. Thus, it cannot be made positive by animal hemoglobin from food. The automated reading of this test also guarantees better reliability.
Information campaign
General practitioners will be informed from March and then trained in the characteristics and use of the new test from April before they can order the new screening kits which will be available in the spring. In particular, they will be able to order them from the professional area of the ameli.fr site.
An information campaign to publicize this new test and invite people aged 50 to 74 to get tested every two years will be launched in the spring. 16 million people are affected.
Colorectal cancer is the third most common cancer in men and the second in women, occurring mainly in those over 50 years of age. In France, there are more than 42,000 new cases each year. This cancer is the second deadliest cancer, responsible for more than 17,500 annual deaths.
.